Travere to present new FILSPARI data at ASN Kidney Week 2026
Travere said it will present new data supporting FILSPARI (sparsentan) as a foundational treatment in IgA nephropathy and FSGS at ASN Kidney Week 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Travere to Present New Data on FILSPARI® at ASN Kidney Week
Travere Therapeutics announced it will present nine new data presentations on FILSPARI® (sparsentan) at the American Society of Nephrology (ASN) Kidney Week 2026, including five oral presentations. The data supports FILSPARI®'s role as a foundational treatment for IgA Nephropathy and FSGS.